AskTheDate.com
Back to calendar

Allogene Therapeutics, Inc. (ALLO) Earnings

ALLO reports earnings on Wednesday, August 12, 2026

earnings report
August 12, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.17
Actual EPS: $-0.18
EPS surprise: 5.32%
Company overview
Market Cap$693.8M
PriceUSD 2.01
EPS (TTM)-0.77
52-week high4.46
52-week low0.99
SectorHealth Technology
IndustryBiotechnology
Employees152